Linden Thomas Advisory Services’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$424K Sell
20,664
-21
-0.1% -$481 0.03% 423
2026
Q1
$456K Buy
20,685
+1,065
+5% +$18.5K 0.04% 391
2025
Q4
$231K Sell
19,620
-921
-4% -$11.8K 0.02% 465
2025
Q3
$325K Buy
20,541
+545
+3% +$7.91K 0.03% 411
2025
Q2
$229K Sell
19,996
-149
-0.7% -$1.68K 0.03% 461
2025
Q1
$273K Buy
20,145
+259
+1% +$4.3K 0.04% 426
2024
Q4
$336K Sell
19,886
-402
-2% -$7.82K 0.04% 417
2024
Q3
$412K Sell
20,288
-112
-0.5% -$2.29K 0.06% 391
2024
Q2
$460K Buy
+20,400
New +$534K 0.07% 367

Other funds holding CC

Linden Thomas Advisory Services's CC Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its Chemours (CC) stake by 0.1% in Q2 2026, selling an estimated $481 and leaving 20,664 shares worth $424K. The position accounts for 0.03% of the portfolio, ranked #423.

Linden Thomas Advisory Services first reported a position in CC in Q2 2024 and has held it in 9 quarters since. The position peaked at $460K in Q2 2024. 104 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Linden Thomas Advisory Services held 20,664 shares of Chemours worth $424K as of Q2 2026.
  • Linden Thomas Advisory Services sold 21 Chemours shares in Q2 2026, an estimated $481.
  • Chemours made up 0.03% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #423 holding.
  • Linden Thomas Advisory Services first reported a position in Chemours in Q2 2024 and has held it in 9 quarters since.
  • Linden Thomas Advisory Services's Chemours position peaked at $460K in Q2 2024.
  • 104 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.